Serial Number 88667826
Registration 6471690
700

Registration Progress

Application Filed
Oct 24, 2019
Under Examination
May 12, 2020
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered
Aug 31, 2021

Basic Information

Serial Number
88667826
Registration Number
6471690
Filing Date
October 24, 2019
Registration Date
August 31, 2021
Published for Opposition
March 17, 2020
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 31, 2021
Registration
Registered
Classes
001 005 042

Rights Holder

INNATE PHARMA S.A.

03
Address
117, AVENUE DE LUMINY
MARSEILLE 13009
FR

Ownership History

INNATE PHARMA S.A.

Original Applicant
03
MARSEILLE FR

INNATE PHARMA S.A.

Owner at Publication
03
MARSEILLE FR

INNATE PHARMA S.A.

Original Registrant
03
MARSEILLE FR

Legal Representation

Attorney
Ian W. Gillies

USPTO Deadlines

Next Renewal Deadline
784 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-31)
Due Date
August 31, 2027
Grace Period Ends
February 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description
Aug 31, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 29, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 28, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 8, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jul 7, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 25, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 25, 2021 IUAF S USE AMENDMENT FILED
May 13, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
May 11, 2021 EXT2 S SOU EXTENSION 2 FILED
May 11, 2021 EX2G S SOU EXTENSION 2 GRANTED
Nov 11, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 9, 2020 EXT1 S SOU EXTENSION 1 FILED
Nov 9, 2020 EX1G S SOU EXTENSION 1 GRANTED
May 12, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2020 ALIE A ASSIGNED TO LIE
Feb 5, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN
Feb 5, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED
Feb 5, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 5, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 5, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 29, 2020 DOCK D ASSIGNED TO EXAMINER
Oct 31, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 30, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Reagents used for scientific and research use; reagents, namely, antibodies and antibody fragments for scientific and research use
First Use Anywhere: Jun 30, 2005
First Use in Commerce: Jun 30, 2005
Class 005
Drugs, pharmaceuticals, cell preparations, vaccines and vaccine adjuvants, therapeutic antibodies and other reagents used in the diagnosis, prevention, monitoring and treatment of disease or disorders, namely, for cancer, infectious diseases, transplantation, inflammation and immune disorders
First Use Anywhere: Jun 30, 2005
First Use in Commerce: Jun 30, 2005
Class 042
Medical and scientific research and development, namely, screening, evaluation, development and conducting clinical trials of therapeutic, preventative and diagnostic compositions and treatments; research in the fields of biochemistry, biotechnology, and clinical trials; pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials via the internet
First Use Anywhere: Jun 30, 2005
First Use in Commerce: Jun 30, 2005

Additional Information

Design Mark
The mark consists of two overlapping circles and an irregular oval shape within and to the left of the two circles.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 042